%0 Generic
%T Phase II study of S-1 plus oxaliplatin (OX) at dose of 130 mg/m2 (SOX130) in Japanese patients (pts) with advanced gastric cancer (AGC).
%A Kito, Yosuke
%A Machida, Nozomu
%A Hamauchi, Satoshi
%A Tsushima, Takahiro
%A Todaka, Akiko
%A Yokota, Tomoya
%A Yamazaki, Kentaro
%A Fukutomi, Akira
%A Onozawa, Yusuke
%A Tsuji, Kunihiro
%A Doyama, Hisashi
%A Haraguchi, Yutaka
%A Nakashima, Koji
%A Kunieda, Kenji
%A Taku, Keisei
%A Mori, Keita
%A Yasui, Hirofumi
%I American Society of Clinical Oncology (ASCO)
%@ 0732-183X
%@ 1527-7755
%K Cancer Research
%K Oncology
%D 2017
%C American Society of Clinical Oncology (ASCO)
%U http://slubdd.de/katalog?TN_libero_mab2
Download citation